Atlas Trials

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets

Clinical trial NCT04853498 · TERMINATED

Trial details

NCT number
NCT04853498
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2021-06-09
Primary completion
2024-04-30
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.